10-K: Quarta-Rad, Inc. Reports Net Loss for Fiscal Year 2024 Amidst Revenue Decline

Quarta-Rad, Inc. reports a net loss of $216,755 for the fiscal year ended December 31, 2024, driven by a significant decrease in revenue compared to the previous year.

Summary

• Quarta-Rad, Inc. reported a net loss of $216,755 for the fiscal year ended December 31, 2024, a significant downturn compared to the net profit of $44,492 in 2023.
• The company's revenue decreased by 78.99% to $106,797 in 2024 from $508,316 in 2023, primarily due to reduced inventory and timing of revenue recognition in Sellavir.
• Operating expenses increased by 25.71% to $246,549 in 2024, compared to $196,129 in 2023, driven by higher general and administrative expenses.
• As of December 31, 2024, Quarta-Rad had $63,021 in cash and a working capital deficit of $260,907.
• The company's ability to continue as a going concern is dependent on securing additional financing and achieving profitable operations.
• Sellavir, Inc., a subsidiary of Quarta-Rad, is focusing on developing CenterEye, a call center software platform leveraging AI and advanced analytics.
• The company discontinued the RADEX series at the end of 2023, eliminating reliance on Quarta-Rad Ltd, a Russian producer.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to the significant revenue decline, net loss, and concerns about the company's ability to continue as a going concern. The identified material weaknesses in internal control further contribute to the negative sentiment.

Positives

• Sellavir is strategically focusing on harnessing its advanced AI capabilities and extensive experience to innovate within the call center industry.
• The company maintains ownership of the RadexRead components source code and is investigating the potential for its compatibility with the SMADEV series.
• The company is actively monitoring the situation regarding the Russian invasion of Ukraine and working closely with their suppliers and logistics companies to mitigate the impact.
• The company has found another potential factory to supply inventory in Kazakhstan.

Negatives

• The company experienced a significant decrease in revenue, falling from $508,316 in 2023 to $106,797 in 2024.
• The company reported a net loss of $216,755 for 2024, a stark contrast to the net profit of $44,492 in the previous year.
• Operating expenses increased to $246,549 in 2024, up from $196,129 in 2023.
• As of December 31, 2024, the company's cash reserves stood at $63,021, with a working capital deficit of $260,907.
• The company's ability to continue as a going concern is dependent on securing additional financing and achieving profitable operations.
• The company discontinued the RADEX series at the end of 2023, eliminating reliance on Quarta-Rad Ltd, a Russian producer.

Risks

• The company's ability to continue as a going concern is dependent on securing additional financing and achieving profitable operations.
• The success of call center product, CenterEye, depends on our ability to develop features that meet client needs, keep up with technological advancements, and address any software bugs or security vulnerabilities promptly.
• There is no guarantee that CenterEye will achieve market acceptance.
• The company has identified material weaknesses in its internal control over financial reporting, including an ineffective control environment and ineffective controls over the financial statement close and reporting process.
• The Russian invasion of Ukraine has adversely impacted the company's ability to purchase inventory.

Future Outlook

The company anticipates increasing revenues through Sellavir's software development and is focusing on expanding its reseller network and strengthening its presence on e-commerce sites. Sellavir is strategically focusing on harnessing its advanced AI capabilities and extensive experience to innovate within the call center industry.

Management Comments

• Management is implementing several plans to alleviate the conditions, giving rise to substantial doubt about the company's ability to continue as a going concern.
• Management intends to focus on raising funds going forward.

Industry Context

The detection device industry is highly competitive, with Quarta-Rad competing against companies with greater financial resources. Sellavir is attempting to enter the call center software market, which is dominated by large players such as Genesys and Nice.

Comparison to Industry Standards

• The document mentions competitors such as United Technologies Corporation, Radiation Alert, Osun Technologies, Lutron, General Tools, Mazur Instruments, First Alert, Inc./BRK Brands, Inc., which is wholly owned by Sunbeam Corporation.
• These companies generally have greater financial and other resources than Quarta-Rad.
• The document does not provide specific comparisons of financial performance against these competitors.

Management Changes

Legal Proceedings

• The Company had a multi-year VAT tax examination by certain European tax authorities.

Related Party Transactions

• The company sells radiation monitors and to date purchased all of it inventory from Quarta-Rad, LTD (QRR), a company in Russia, which is owned by the company's minority shareholder, who disposed of their interest in 2024, through 2022.
• In May 2022, the company began using Star Systems Corporation (STAR:), a Japanese entity owned by the company's majority shareholder, as an intermediary to purchase inventory from QRR.
• During July 2017 the company entered into an agreement with the Russian affiliate to develop and update software for a new device for $180,000.
• In April 2021, the company began compensating its CEO, who is the majority shareholder.
• From time to time the CEO advanced funds for operations.
• During 2024 and 2023, the company, through Sellavir, Inc recognized $40,000 and $187,000, respectively, in services to STAR to develop software.

Stakeholder Impact

• Shareholders face the risk of a total loss of their investment if the company is unable to fund its operations or remain in business.
• Employees may be impacted by cost-reduction strategies and potential changes in the company's business plan.
• Customers may be affected by the discontinuation of the RADEX series and the company's ability to provide quality products and services.
• Suppliers may be impacted by the company's financial difficulties and potential changes in its purchasing patterns.
• Creditors face the risk of non-payment if the company is unable to secure additional financing and achieve profitable operations.

Next Steps

• The company intends to purchase inventory to increase sales.
• The company intends to increase marketing efforts on the Internet to generate leads and sales.
• The company plans to seek and secure distribution agreements for the sale of its detection devices.
• The company will continue to strengthen its presence on e-commerce sites.
• The company is also focusing on expanding its reseller network by targeting large consumer retail chains.

Key Dates

Keywords

Financial Results, Net Loss, Revenue Decline, Quarta-Rad, Sellavir, CenterEye, AI, Radiation Detection, Going Concern, Internal Controls